-
公开(公告)号:US20160166666A1
公开(公告)日:2016-06-16
申请号:US14904525
申请日:2014-07-11
发明人: Keiki Masuda , Haruhisa Iguchi , Masashi Goto , Toshihiko Torigoe , Yoshihiko Hirohashi , Rena Morita
IPC分类号: A61K39/00 , C07K16/28 , C07K14/74 , C07K14/705 , A61K38/17
CPC分类号: A61K39/0011 , A61K38/177 , A61K2039/55566 , A61K2039/57 , C07K14/4747 , C07K14/705 , C07K14/70539 , C07K16/2833 , C07K16/30 , C07K2317/32
摘要: Provided is a tumor antigen peptide and the like that is useful in the prevention and/or treatment of cancer. The present invention pertains to: a peptide comprising the amino acid sequence of sequence number 3, sequence number 4, sequence number 5, sequence number 6, or sequence number 11; a polyepitope peptide resulting from joining a plurality of epitope peptides and containing at least one of the aforementioned peptides as one epitope peptide; a polynucleotide coding for at least one of the polyepitope peptides or the peptides; a pharmaceutical composition containing the above as active ingredients; a cancer prevention and/or treatment agent characterized by inducing CTLs; and the like.
摘要翻译: 提供可用于预防和/或治疗癌症的肿瘤抗原肽等。 本发明涉及:包含序列号3,序列号4,序列号5,序列号6或序列号11的氨基酸序列的肽; 通过连接多个表位肽并含有至少一个前述肽作为一个表位肽而产生的多表位肽; 编码至少一种多表位肽或多肽的多核苷酸; 含有上述作为活性成分的药物组合物; 特征在于诱导CTL的癌症预防和/或治疗剂; 等等。